Stock listing

LS Exchange:A3CVW1 Cytek Biosciences, Inc. Aktie

German listing (LS Exchange) of Cytek Biosciences, Inc. · home listing NASDAQ:CTKB

Follow Cytek Biosciences, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CTKB

$5.25 USD 0.00 (0.0%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CTKB

Since Jul 6, 2026 +13.6% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$5.19 – $5.34 USDOct 19, 2026
Volume
700,551 sharesOct 19, 2026
Market value
$682.4M USDAt the close on Oct 19, 2026 · price × 130.0M shares outstanding
Cytek Biosciences, Inc. logo
Ticker
LS Exchange:A3CVW1
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LS Exchange
Currency
EUR

What changed lately

Calls

Replays

  • Cytek Biosciences (NASDAQ:CTKB) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 4:30 PM ET

    Watch Transcript
  • Cytek Biosciences (NASDAQ:CTKB) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 4:30 PM ET

    Watch Transcript
  • Cytek Biosciences (NASDAQ:CTKB) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

All Cytek Biosciences, Inc. news

Decks

Cytek Biosciences, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
21 in the last 12 months · 90 in all · newest Sep 23, 2026 · oldest 2021
Calls
20 calls with a replay · 20 with a transcript · latest Aug 5, 2026
Decks
11 decks · latest Aug 5, 2026

Where Cytek Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CTKB · Home listingNASDAQUnited StatesUSD
gettex:8EQgettexGermanyEUR
LS Exchange:A3CVW1 · This pageLS ExchangeGermanyEUR
Lang & Schwarz:A3CVW1Lang & SchwarzGermanyEUR
Tradegate:8EQTradegateGermanyEUR
BOATS:CTKBBOATSUnited StatesUSD
Dusseldorf:8EQDusseldorfGermanyEUR
Frankfurt:8EQFrankfurtGermanyEUR
Munich:8EQMunichGermanyEUR
Stuttgart:8EQStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Cytek Biosciences, Inc.